NCT02355535 2020-09-24Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 1Vanquish Oncology, Inc.Phase 1 Completed48 enrolled
NCT00958841 2016-07-26Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine OriginNovartisPhase 2 Terminated118 enrolled 11 charts
NCT01628913 2016-04-07Efficacy and Safety of BEZ235 Compared to Everolimus in Patients With Advanced Pancreatic Neuroendocrine TumorsNovartisPhase 2 Terminated62 enrolled 7 charts
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts
NCT00006368 2013-05-01Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent CancerNovartisPhase 1 Completed60 enrolled